Microvessel Density and Clinicopathologic Characteristics in Hepatocellular Carcinoma With and Without Cirrhosis by Chebib, Ivan et al.
Biomarker Insights 2007: 2 59–68 59
ORIGINAL RESEARCH
Correspondence: Zu-hua Gao, M.D., Ph.D., Department of Pathology and Laboratory Medicine, Foothills Medical 
Center, University of Calgary, Room C1150E, 1403-29 Street NW, Calgary, Alberta, Canada T2N 2T9. 
Tel: 403 944 8506; Fax: 403 944 4748; Email: zu-hua.gao@cls.ab.ca
Please note that this article may not be used for commercial purposes. For further information please refer to the copyright 
statement at http://www.la-press.com/copyright.htm
Microvessel Density and Clinicopathologic Characteristics 
in Hepatocellular Carcinoma With and Without Cirrhosis
Ivan Chebib, Meer Taher Shabani-Rad, Michelle S. Chow, James Zhang
and Zu-hua Gao
Department of Pathology and Laboratory Medicine, University of Calgary and Calgary Laboratory 
Services, Calgary, Alberta, Canada.
Abstract: Angiogenesis is essential to the survival, growth, invasion, and metastasis of various human solid tumors. We 
compared the microvessel density (MVD) and clinicopathologic features of two different groups of hepatocellular carci-
noma (HCC), namely HCC with cirrhosis (HCC-C) and without cirrhosis (HCC-NC). A tissue microarray composed of 20 
normal livers, 20 cirrhotic livers, tumor and adjacent background non-neoplastic liver tissues from 20 HCC-C and 20 HCC-NC 
were constructed and stained immunohistochemically with antibodies against the antigen CD34. The MVD was determined 
by the measurement of the area and density of CD34 positive sinusoidal endothelial cells using the Image Pro Plus software. 
There was a trend of increased MVD in cirrhotic liver compared to normal liver and in cirrhotic background non-neoplas-
tic liver adjacent to the tumor compared to the non-cirrhotic background non-neoplastic liver. Tumor tissue of HCC-C and 
HCC-NC both showed signiﬁ  cantly higher MVD than their adjacent background non-neoplastic liver tissue. There was no 
statistical difference in MVD between HCC-C and HCC-NC. A higher value of MVD was seen in tumors of intermediate 
size (5–10 cm), high histologic grade, the presence of lymphvascular space invasion, and the underlying etiology of hepa-
titis C and alcoholic steatohepatitis. This data indicates that MVD may play an important role in liver carcinogenesis and 
neoplastic progression. The difference in clinical behavior between HCC-C and HCC-NC does not seem to be associated 
with differences in tumor MVD. Objective measurement of MVD using standardized computer software could potentially 
be used as a clinical marker to predict patients’ prognosis.
Abbreviations: CL: cirrhotic liver; HCC-CB: non-neoplastic cirrhotic background liver tissue adjacent to the tumor; HCC-C: 
tumor tissue of HCC with cirrhosis; HCC-NCB: non-neoplastic non-cirrhotic background liver tissue adjacent to the tumor; 
HCC-NC: tumor tissue of HCC without cirrhosis; MVD: microvessel density; NL: normal liver.
Keywords: hepatocellular carcinoma; cirrhosis; microvessel density; tissue microarray; immunohistochemistry.
Introduction
Hepatocellular carcinoma (HCC) is the sixth most common cancer worldwide in terms
 of numbers of 
cases but
 because of its very poor prognosis, it is the third most common
 cause of death from cancer 
(Parkin et al. 2005).
 HCC is multifactorial in etiology and complex in pathogenesis. The major risk 
factor is liver cirrhosis associated with chronic hepatitis B and hepatitis C infection, alcohol, aﬂ  atoxin B 
exposure, and various metabolic disorders (Harris, 1990; Saito et al. 1990; Chen et al. 1996; Johnson, 
1987). However, in approximately 10–40% of patients the tumor arises from a non-cirrhotic liver 
(Nazeako et al. 1996). Patients with HCC with cirrhosis (HCC-C) are signiﬁ  cantly older. The tumor 
from patients with cirrhosis tends to be less well differentiated (high grade), exhibits local portal inva-
sion and metastasis more often than tumors from patients without cirrhosis. Survival advantages of 
HCC without cirrhosis (HCC-NC) over those with cirrhosis have been well documented (Nazeako 
et al. 1996; Kew, 1989; Okuda et al. 1989).
 However,
 the underlying mechanism for these clinico-
pathologic differences is yet uncertain.
The sinusoids of liver are lined by a unique endothelium structurally characterized by the presence 
of fenestrations forming the so-called sieve plates and the absence of a subenthothelial basement membrane 
(Philips et al. 1987). Phenotypically, the sinusoid endothelial cells are characterized by the expression 
of speciﬁ  c markers such as CD4, CD14 and CD32, and by the lack of expression of normal capillary 
endothelial markers such as CD31 and CD34 (Scoazec et al. 1991; Frachon et al. 2001). In hepatocellular Biomarker Insights 2007: 2 60
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carcinoma, the sinusoid endothelial cells lost their 
structural and phenotypic characteristics and 
adopted the structure and phenotype of normal 
capillary endothelial cells, a phenomenon known 
as capillarization (Kin et al. 1994; Nakamura et al. 
1997). The association of increased expression of 
vascular endothelial growth factor, basic ﬁ  broblast 
growth factor and hypoxia-inducible factor 1-alpha 
with the capillarization of sinusoidal endothelial 
cells demonstrated in recent studies indicate that 
the ‘capillarization’ phenomenon is not merely a 
change of endothelial cell differentiation, but rather 
represents a process of tumor angiogenesis (Park 
et al. 2000; Imura et al. 2004; Huang et al. 2005). 
Tumor angiogenesis is critical for providing 
nutrient supply to the tumor and providing the route 
for tumor metastasis. Microvessel density (MVD), 
a quantitive measurement of tumor angiogenesis 
has been shown to be of prognostic value in many 
types of malignancy including HCC (Weidner, 
1995; Poon et al. 2002).
Variable degrees of sinusoidal endothelial capil-
larization have also been observed in the cirrhotic 
liver of human and animal models (Huet et al. 1985; 
Lu X et al. 2003; Xu et al. 2003), which became 
more consistent in dysplastic nodules in cirrhotic 
liver. Therefore, capillarization of sinusoidal endo-
thelial cells was considered part of the carcinogen-
esis process in HCC-C. HCC-NC lacks the process 
of pre-existing hepatitis and cirrhosis. There is no 
study yet to address the differences of MVD in the 
tumor and its adjacent background non-neoplastic 
liver between HCC and HCC-NC. In this study, we 
used the area and intensity of CD34 positive sinu-
soid endothelial cells as a measurement of MVD 
and compared their value between normal liver and 
cirrhotic liver, between the non-neoplastic back-
ground liver adjacent to HCC-C (HCC-CB) and 
the non-neoplastic background liver adjacent to 
HCC-NC (HCC-NCB), and between the tumor 
tissue of HCC-C and HCC-NC. The quantitive data 
of MVD was then analyzed in correlation with the 
clinicopathologic characteristics.
Materials and Methods
Tissue samples
With the approval of the institutional review board 
of the University of Calgary, we retrieved the 
following tissue samples from the Department of 
Pathology, University of Calgary: 20 normal livers 
(15 men and 5 women; age range 29–100 years), 
20 cirrhotic livers (11 men and 9 women; age range 
39–89 years), tumors and their adjacent background 
non-neoplastic livers from 20 HCC-C (15 men and 
5 women, age range 44–75 years) and 20 HCC-NC 
(17 men and 3 women, age range 25–85 years). 
The tissue samples of normal liver and cirrhotic 
liver were obtained from well-preserved autopsy 
specimens. The tissue samples of tumors and their 
adjacent background non-neoplastic livers were 
obtained from surgical resection specimens. 
Routine hematoxylin-eosin stained tissue sections 
were reviewed by 2 pathologists (IC, ZG) and the 
tumors were graded using the WHO grading system 
(Hirohashi, 2000). HCC-NC was deﬁ  ned by the 
absence of bridging ﬁ  brosis in the background 
non-neoplastic liver tissue. Representative areas 
were selected for the construction of the tissue 
microarray blocks using 1.0 mm punchers on the 
manual tissue arrayer MTA-1 (Beecher Instru-
ments, Sun Prairie, WI).
 The background non-
neoplastic liver tissue was sampled within 0.5
 cm 
distance to the tumor. The tumor tissue was sampled 
from growing edge where the maximal MVD is 
believed to exist (Weidner, 1995).
Clinical information
The demographic data, background liver diseases, 
date of HCC diagnosis, date and vital status (living 
or deceased) of last follow up, cause of death (due 
to HCC or other causes), disease-speciﬁ  c survival 
(from date of diagnosis to date of death), tumor size, 
location, stage, type of surgery, recurrences, intra- 
and extrahepatic metastasis were obtained by 
reviewing the patients’ medical charts and commu-
nication with attending physicians. Patients were 
censored at the latest date when they were seen alive 
or at the date of their non-tumor-related death.
Immunohistochemistry
Immunohistochemical staining was performed on 
4 µm sections obtained from formalin-fixed, 
parafﬁ  n-embedded tissue microarray blocks. After 
deparafﬁ  nization and rehydration, tissue sections 
were incubated with monoclonal antibodies against 
CD34 (mouse clone QBEnd/10, dilution 1:200, 
Novocastra, Norwell, MA). A subsequent reaction 
was performed with biotin-free horseradish perox-
idase labeled polymer of EnVision plus detection 
system (DakoCytomation, Carpinteria, CA). A 
positive reaction was visualized with diaminoben-Biomarker Insights 2007: 2 61
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zidine solution followed by counterstaining with 
hematoxylin. Placenta tissue was used as the posi-
tive control according to the manufacturers’ recom-
mendation. Negative controls were prepared by 
using non-immune mouse IgG.
Evaluation of MVD
The evaluation of MVD was performed without 
knowledge of clinicopathologic data. The intensity 
and area of sinusoidal endothelial staining were 
quantitively measured using the Image Pro Plus 
5.0 software (Media Cybernetics, Inc, Silver 
Spring, MD). The entire tissue core (1 mm
2) of 
each case in the array excluding the microvessel 
and connective tissue was measured at a magniﬁ  -
cation of 100x. The images were then imported 
into the Image-Pro Plus software, where they were 
calibrated to a known area of measurement. The 
immunohistochemical stain was then selected 
using the “color selection” function and the “area/
density (intensity) measurement” functions were 
used to calculate the respective values. These 
values were then transferred onto the clipboard and 
placed into a Microsoft Excel worksheet.
Statistical Analysis
The data were compiled in a Microsoft Excel 
spreadsheet and analyzed using STATA 9.0 soft-
ware (StataCorp, College Station, TX). Fisher’s 
exact test and chi-square analysis were used for 
comparing the clinicopathologic parameters 
between HCC-C and HCC-NC. Survival data were 
analyzed by Kaplan-Meier survival estimates and 
log-rank tests. Non-parametric multiple analysis 
of variance (ANOVA) was used to see the effect 
of a categorical variable (normal liver, cirrhotic 
liver, etiology, histologic grade, tumor size, etc) 
on dependent variables (CD34 area and intensity). 
Student t-test was used to compare paired samples 
i.e. HCC-C vs. HCC-CB and HCC-NC vs. 
HCC-NCB. Mann-Whitney U test was used for the 
comparison of unpaired samples, i.e. HCC with 
and without lymphvascular invasion.
Results
Clinical and pathologic characteristics
Comparison of clinicopathologic parameters 
between hepatocellular carcinomas with and 
without cirrhosis is summarized in Table 1. 
Hepatitis of virus and alcoholic etiology were more 
commonly seen in patients suffering from HCC-C. 
In the HCC-NC group, less than 1/2 were normal, 
an equal number had diagnosable disease, and 4 
had “unknown” hepatitis. Despite the lack of statis-
tical differences between HCC-C and HCC-NC in 
patients’ age, gender, tumor histologic type (except 
ﬁ  brolamellar carcinoma only seen in HCC-NC), 
grade, size, multiplicity, lymphvascular space inva-
sion, tumor stage and surgical margins, patients 
with HCC-NC enjoyed a significantly longer 
period of disease-free survival than patients with 
HCC-C (Figure 1).
The area and intensity of sinusoidal 
CD34 positive cells
Figure 2 shows the area of CD34 positive sinu-
soidal endothelial cells in different types of tissue. 
Figure 3 shows the intensity of CD34 positive 
sinusoidal endothelial cell staining in different 
types of tissue. Figure 4 shows the representative 
images of CD34 staining in different types of 
tissue. There was a trend of increased CD34 posi-
tive area and intensity in cirrhotic livers than 
normal livers and in HCC-CB than HCC-NCB. 
There was no signiﬁ  cant difference between HCC-C 
and HCC-NC in both area and intensity of CD34 
sinusoidal endothelial cell staining. Comparisons 
with their relevant background non-neoplastic liver 
tissue, both HCC-C and HCC-NC showed a statis-
tically signiﬁ  cant increase in both area and inten-
sity of CD34 sinusoidal endothelial cell staining.
Correlation of microvessel intensity 
with clinicopathologic characteristics
Table 2 shows the correlation of the mean value of 
both the area and intensity of CD34 sinusoidal 
endothelial staining with the presence or absence 
of lymphvascular space invasion, tumor size, 
histologic grade and the underlying etiology. 
Although not statistically signiﬁ  cant, a higher 
MVD value was seen in HCCs with lymphvascular 
space invasion, high histologic grade, medium 
tumor size (5–10 cm), and the underlying etiology 
of hepatitis C and alcoholic steatohepatitis.
Discussion
Von Willebrand’s factor (vWF), CD31, and CD34 
are commonly used markers for highlighting endo-
thelial cells in normal tissue. Antibodies against Biomarker Insights 2007: 2 62
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vWF and CD31 have failed to stain sinusoid endo-
thelial cells in many HCC cases, whereas CD34 
has proven to be a more sensitive and speciﬁ  c 
endothelial cell marker for microvessels in HCC 
(McComb et al. 1982; Simmons et al. 1990; Ruck 
et al. 1995). The presence of CD34 positive, vWF-
negative sinusoidal endothelial cells in HCC was 
further verified by more detailed comparative 
studies (Tanigawa et al. 1997; Ohmori, 2001). 
CD34 is a 110-kd, heavily glycosylated transmem-
brane protein that is present in hematopoietic 
progenitor cells and endothelial cells (Fina et al. 
1990). Due to its preferential expression on the 
surface of regenerating or migrating endothelial 
cells, CD34 has been used as a marker of prolifer-
ating endothelial cells in the growing sprouts 
during angiogenesis (Schlingermann et al. 1990). 
It has been recently demonstrated that bone-
marrow-derived CD34 positive endothelial 
progenitor cells migrate through the blood circula-
tion and are incorporated into the site of angiogen-
esis (Asahara et al. 1997; Shi et al. 1998). In this 
study, we attempted to stain our tissue array with 
antibodies against CD31 (data not shown), vWF 
(data not shown) and CD34. Only CD34 showed 
consistent positive staining in tumor tissue. Our 
 Table 1. Comparison of clinicopathologic parameters between hepatocellular carcinoma with and without 
cirrhosis.
Parameters HCC-C  HCC-NC  p  value*
Age       0.707
 <  50  yrs  6  4
 >50  yrs  14  16
Gender       0.695
 Male  15  17
 Female  5  3
Background liver disease      0.002
 Hepatitis  B  8  2
 Hepatitis  C  7  1
 Non-speciﬁ  c hepatitis  0  4
 Alcoholic  steatohepatitis  3  5
 None  2  8
Histology type      0.231
 Classic  20  17
 Fibrolamellar  0  2
 Sclerosing  0  1
Tumor size      0.200
 <5  cm  11  6
 >5  cm  9  14
Tumor multiplicity      1.000
 Solitary  14  13
 Multiple  6  7
Tumor Grade (WHO)      0.381
 I  0  2
 II  17  14
 III  3  4
 IV  0  0
Lymphvascular invasion      0.523
 Present  7  10
 Absent  13  10
Tumor Stage      0.875
 I  10  10
 II  4  3
 III  3  5
 IV  3  2
Surgical margin  all negative  all negative
   3  N/A  4N/A
HCC-C: hepatocellular carcinoma with cirrhosis; HCC-NC: hepatocellular carcinoma without cirrhosis.
* Fisher’s exact test and chi-square analysis.Biomarker Insights 2007: 2 63
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Figure 1. Kaplan-Meier survival estimates. In comparison with hepatocellular carcinoma patients with cirrhosis. (HCC-C), hepatocellular 
carcinoma patients without cirrhosis (HCC-NC) showed a signiﬁ  cantly longer disease-free survival (p < 0.05, log-rank test).
Figure 2. Area of CD34 positive sinusoidal endothelial cells in different types of tissue. CL: cirrhotic liver; HCC-CB: non-neoplastic 
cirrhotic background liver tissue adjacent to the tumor; HCC-C: tumor tissue of HCC with cirrhosis; HCC-NCB: non-neoplastic non-cirrhotic 
background liver tissue adjacent to the tumor; HCC-NC: tumor tissue of HCC without cirrhosis; NL: normal liver.
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data is therefore analyzed based on the intensity 
and area of CD34 positive sinusoidal endothelial 
cell staining in different types of tissue. Manual 
microscopic count was used previously for the 
assessment of intratumor microvessel density 
(Mazzanti et al. 1997; Tanigawa et al. 1997; Sun 
et al. 1999; Poon et al. 2002; Lu et al. 2004). A 
computer image analyzer was used in this study 
for the assessment of the area and intensity of 
immunohistochemical staining to increase accu-
racy and to avoid inter-observer variation. The 
standardized technology provides more objective 
measurements of MVD and makes it more feasible 
for future clinical applications.
We found a trend of higher MVD in cirrhotic 
liver than normal liver and in HCC-CB than 
HCC-NCB. This observation is consistent with 
reports from other authors (El-Assal et al. 
1998;Yamamoto et al. 1998; Ruck et al. 1995; Cui 
et al. 1996; Frachon et al. 2001). The increased 
MVD in cirrhotic liver was generally considered 
part of carcinogenesis process in HCC arising from 
cirrhotic liver (Messerini L. et al. 2004). Despite 
the lack of pre-existing cirrhosis, HCC-NC also 
had a signiﬁ  cantly higher MVD than the back-
ground non-neoplastic liver. Therefore, increased 
MVD is not unique for HCC-C, but rather a 
universal process associated with neoplastic trans-
formation in HCC. The signiﬁ  cant differences in 
MVD between tumor tissue and their background 
non-neoplastic liver tissue in both HCC-C and 
HCC-NC suggests the association of sinusoidal 
capillarization with neoplastic transformation 
irrespective of the pre-existence or absence of 
cirrhosis. The clinical difference between patients 
with HCC-C and patients with HCC-NC seems 
unrelated to microvessel density in the tumor and 
their surrounding non-neoplastic liver tissue.
Reports about the association of underlying 
liver diseases with the MVD in the HCC and 
non-neoplastic liver have been conflicting 
(El-Assai et al. 1998; Mazzanti et al. 1997; Ohmori 
Figure 3. Intensity of CD34 positive sinusoidal endothelial cells in different types of tissue. CL: cirrhotic liver; HCC-CB: non-neoplastic 
cirrhotic background liver tissue adjacent to the tumor; HCC-C: tumor tissue of HCC with cirrhosis; HCC-NCB: non-neoplastic non-cirrhotic 
background liver tissue adjacent to the tumor; HCC-NC: tumor tissue of HCC without cirrhosis; NL: normal liver.
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Figure 4. Representative images of CD34 staining in different types of tissue (original magniﬁ  cation x200). A) CD34 staining in normal liver. 
B) CD34 staining in cirrhotic liver without tumor. C) CD34 staining in the background non-neoplastic liver tissue adjacent to HCC without 
cirrhosis. D) CD34 staining in the tumor tissue of HCC without cirrhosis. E) CD34 staining in the background non-neoplastic liver tissue 
adjacent to HCC with cirrhosis. F) CD34 staining in the tumor tissue of HCC with cirrhosis.Biomarker Insights 2007: 2 66
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et al. 2001; Urashima et al. 1993). The most recent 
study suggests that HCV associated HCC has a 
signiﬁ  cantly higher value of MVD both in the 
tumor and non-tumorous areas compared to the 
equivalent in HBV, which indicate a closer link 
between HCV infection with angiogenesis and 
hepatocarcinogenesis (Messerini et al. 2004). In 
our group, HCV-HCC had a higher MVD than 
HBV-HCC. More interestingly, we found that 
alcohol-associated HCC had the highest value of 
MVD. Although the association between early 
alcoholic liver diseases with capillarization of 
sinusoids has been documented in previous studies 
(Popper et al. 1981; Horn et al. 1985; Urashima et 
al. 1993), our study, for the ﬁ  rst time, demonstrated 
a high value of intratumoral MVD in the alcoholic 
steatohepatitis related HCC. In our study group, a 
significant number of patients with HCC-NC 
(25%) had underlying alcoholic steatohepatitis, 
which might contribute to the increased MVD in 
HCC-NC. The differences in MVD among HCC 
arising from different liver diseases are an inter-
esting area deserving further investigation.
Angiogenesis is critical for tumor growth 
because it provides the oxygen and nutrition that 
is required by the proliferating malignant cells. 
Unlike other solid tumors, increased MVD was 
only observed in small to medium sized HCCs. 
Some have reported an inverse correlation between 
tumor size and MVD in HCC (Ng et al. 2001; Poon 
et al. 2002; Lu et al. 2004). Based on their study 
of 71 resected hepatocellular carcinomas, El-Assal 
et al. (1998) concluded that angiogenesis plays a 
fundamental role in the tumor proliferation of 
HCCs 2–5 cm in diameter, whereas, the importance 
of neovascularization is reduced as the tumors 
became larger. Similarly, Tanigawa et al. (1997) 
found increased vascularity in tumors greater than 
2 cm. We found that tumors of 5–10 cm in diameter 
had the highest MVD compared with larger and 
smaller sized tumors. Tumors that fall into this size 
range may be in an ideal condition for receiving 
nutritional supply from the circulation. Larger 
sized tumors with lower MVD may have perfusion 
deﬁ  ciencies, which will eventually lead to tumor 
necrosis. On the other hand, tumors of 5 to 10 cm 
in diameter may be at the best size window for 
chemotherapy due to the relative easiness in trans-
porting medications into the tumor.
The association of high MVD-CD34 with high 
histological grade, the presence of lymphvascular 
space invasion, the presence of satellite lesions, 
high post-surgical tumor recurrence rate, high 
metastasis rate and poor disease-free survival has 
been observed in many studies (Tanigawa et al. 
1997; El-Assal et al. 1998; Sun et al. 1999; Poon 
et al. 2002; Zhang et al. 2006; Yamamoto et al. 
1998; Yao et al. 2005). The trend of increased MVD 
with the progression of HCC from low to high 
histologic grade and the presence of lymphvascular 
Table 2. Correlation of microvessel density with clinicopathologic characteristics.
  CD34 area  CD34 intensity  p value
 (mean,  mm
2) (mean  × 10
5) Statistical  analysis
Lymphvascular
invasion    Area:  0.927
Yes 0.015  249  Intensity:  0.783
No 0.011  194  Mann-Whitney  test
Histologic grade
I 0.000  1.3  Area:  0.164
II 0.011  192  Intensity:  0.173
III 0.020  360  ANOVA  test
Tumor size
<5 cm  0.008  154  Area: 0.276
5–10cm 0.018  314  Intensity:  0.329
>10 cm  0.012  200   ANOVA test
Etiology
Unknown 0.013  222  Area:  0.409
Alcohol 0.020 347  Intensity:0.459
HBV 0.007  111  ANOVA  test
HCV 0.012  200 
Although statistically not signiﬁ  cant, the mean value of both CD34 area and intensity are higher in HCC with lymphvascular space 
invasion, high histological grade, intermediate tumor size, and the underlying etiology of hepatitis C and alcoholic steatohepatitis.Biomarker Insights 2007: 2 67
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space invasion observed in this study further 
suggests the association of MVD with the progres-
sion of HCC. Therefore, it would be conceivable 
to speculate that a higher level of MVD might be 
an indicator of poor prognosis.
In summary, tumor tissue of HCC-C and 
HCC-NC both showed significantly higher 
microvessel density than their adjacent background 
non-neoplastic tissue. There was no statistical 
difference in MVD between HCC-C and HCC-NC. 
A higher level of MVD was seen in tumors of 
intermediate size (5–10 cm), high histologic grade, 
the presence of lymphvascular space invasion, and 
the underlying etiology of hepatitis C and alcoholic 
steatohepatitis. This data indicates that MVD may 
play an important role in liver carcinogenesis and 
neoplastic progression irrespective of the pre-
existence or absence of cirrhosis. The difference 
in clinical behavior between HCC-C and HCC-NC 
does not seem to be associated with differences in 
tumor MVD. Objective measurement of MVD 
using standardized computer software could poten-
tially be used as a clinical marker to predict 
patients’ prognosis.
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